WALTHAM, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- Great Elm Capital Group, Inc. (NASDAQ: GEC, “Great Elm”) announced its financial results for the quarter ended March 31, 2020. Great Elm will host a conference call and webcast on Tuesday, May 12, 2020 at 8:00 a.m. Eastern Time to discuss its fiscal third quarter 2020 financial results. Please see below for details.

BUSINESS OVERVIEW

Great Elm is a diversified, publicly-traded holding company that seeks to build long-term shareholder value across three verticals: Operating Companies, Investment Management and Real Estate.

During the quarter ended March 31, 2020, we issued $30 million in aggregate principal amount of unsecured convertible notes, bringing our cash balance to approximately $39 million. This capital raise enhances our ability to pursue new investment opportunities.

Select highlights from the fiscal third quarter 2020 include:

“Our DME business has been meaningfully impacted by the COVID-19 pandemic. Nevertheless, DME’s scalable platform has enabled it to adapt to challenging market conditions,” remarked Peter A. Reed, Great Elm’s Chief Executive Officer. “Our Investment Management business had a challenging quarter. In managing Great Elm Capital Corp. (“GECC”), we are focused on preserving liquidity, strengthening its balance sheet and positioning the portfolio to capitalize on attractive potential investment opportunities amid credit market dislocations.”

Alignment of Interest

The employees of Great Elm and Great Elm Capital Management, Inc. (“GECM”) collectively own approximately 2.0 million shares of GEC stock, representing approximately 7% of its outstanding shares. Additionally, the directors of Great Elm collectively own or manage approximately 20% of Great Elm’s shares. Altogether, insiders collectively own or manage approximately 27% of the company’s outstanding shares, which Great Elm believes fosters a strong alignment of interest between employees, directors and the company’s shareholders.

Operating Companies

In the three months ended March 31, 2020, DME generated $2.5 million of adjusted EBITDA. During the quarter, DME experienced meaningful growth in new patient setups in major product categories, including 19.0% in the key PAP segment, year-over-year.

Toward the end of the quarter ended March 31, 2020, local government measures taken to curb the spread of COVID-19 negatively impacted the referral pipeline for sleep studies and new equipment setups.

To date, the investments we’ve made to enhance our scalable platform have helped DME adjust to difficult market conditions and should help position it for further growth in a more normalized environment.

Investment Management

In the three months ended March 31, 2020, Investment Management generated $0.3 million of adjusted EBITDA1, approximately flat year over year. We continue to focus on operational efficiency to drive free cash flow generation.

The first half of 2020 has been characterized by remarkable volatility in the leveraged credit markets, driven by the impact of the COVID-19 pandemic and violent swings in asset prices. The fair value of managed portfolio investments, primarily at GECC, was negatively impacted by this volatility. All GECC portfolio companies are operating in a highly uncertain environment. Nevertheless, a majority of these portfolio companies are weathering the difficult economic environment with resilient business models and sustainable cash flows.

We believe that prudent cash management is paramount during bouts of market volatility. As such, in managing GECC, we remain focused on maintaining significant liquidity and strengthening its balance sheet.

Real Estate

In the three months ended March 31, 2020, Real Estate generated $1.3 million in rental revenue and $1.2 million of adjusted EBITDA.

FINANCIAL REVIEW: SEGMENT FINANCIALS

As of March 31, 2020, Great Elm had four operating segments: Durable Medical Equipment, Investment Management, Real Estate and General Corporate.

Durable Medical Equipment

Three Months Ended March 31, 2020:

Revenue:

Net Income (Loss):

Adjusted EBITDA:

Investment Management

Three Months Ended March 31, 2020:

Revenue:

Net Income (Loss):

Adjusted EBITDA1:

Real Estate

Three Months Ended March 31, 2020:

Revenue:

Net Income (Loss):

Adjusted EBITDA:

General Corporate

Three Months Ended March 31, 2020:

Revenue:

Net Income (Loss):

Adjusted EBITDA:

Conference Call & Webcast

Great Elm will host a conference call and webcast on Tuesday, May 12, 2020 at 8:00 a.m. Eastern Time to discuss its third quarter 2020 financial results.

All interested parties are invited to participate in the conference call by dialing +1 (833) 921-1653; international callers should dial +1 (778) 560-2576. Participants should enter the Conference ID 3197590 when asked. For a copy of the slide presentation that will be referenced during the course of our conference call, please visit: https://www.greatelmcap.com/events-and-presentations/default.aspx.

The conference call will be webcast simultaneously at: https://event.on24.com/wcc/r/2161471/C93C040DDE499685608275DC51E73996.

About Great Elm Capital Group, Inc.

Great Elm is a publicly-traded holding company that seeks to build a business across three operating verticals: Operating Companies, Investment Management and Real Estate. Great Elm’s website can be found at www.greatelmcap.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release that are “forward-looking” statements, including statements regarding expected growth, profitability and outlook involve risks and uncertainties that may individually or collectively impact the matters described herein. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made and represent Great Elm’s assumptions and expectations in light of currently available information. These statements involve risks, variables and uncertainties, and Great Elm’s actual performance results may differ from those projected, and any such differences may be material. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking statements are risks associated with the economic impact of the COVID-19 pandemic on Great Elm’s businesses, including DME as well as GECC and its portfolio investments. For information on certain factors that could cause actual events or results to differ materially from Great Elm’s expectations, please see Great Elm’s filings with the SEC, including its most recent annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. Additional information relating to Great Elm’s financial position and results of operations is also contained in Great Elm’s annual and quarterly reports filed with the SEC and available for download at its website www.greatelmcap.com or at the SEC website www.sec.gov.

Non-GAAP Financial Measures

The SEC has adopted rules to regulate the use in filings with the SEC, and in public disclosures, of financial measures that are not in accordance with US GAAP, such as adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”). Adjusted EBITDA is derived from methodologies other than in accordance with US GAAP. Great Elm believes that Adjusted EBITDA is an important measure for investors to use in evaluating Great Elm’s businesses. In addition, Great Elm’s management reviews Adjusted EBITDA as they evaluate acquisition opportunities.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it either in isolation from, or as a substitute for, analyzing Great Elm’s results as reported under US GAAP. Non-GAAP financial measures reported by Great Elm may not be comparable to similarly titled amounts reported by other companies.

Set forth below is a reconciliation of Adjusted EBITDA to the most directly comparable US GAAP financial measure, net income. The information in the table below represents Great Elm’s assumptions and expectations in light of currently available information. Great Elm’s actual performance results may differ from those projected in the table below, and any such differences may be material.

           
  For the three months ended March 31, 2020
$ in thousands Durable Medical
Equipment
 Investment
Management
 Real Estate General
Corporate
 Consolidated
EBITDA:          
Net income (loss) - GAAP $ (1,398) $ 491  $ 67 $ (11,078) $ (11,918)
Interest expense  906   39   654  155   1,754 
Depreciation & amortization  2,354   150   430  1   2,935 
Income tax expense (benefit)  -   -   -  (148)  (148)
EBITDA $ 1,862  $ 680  $ 1,151 $ (11,070) $ (7,377)
Adjusted EBITDA:          
Stock based compensation  -   (373)  -  106   (267)
Change in contingent consideration  -   -   -  -   - 
GECC Unrealized (gains) / losses  -   -   -  9,794   9,794 
Dividend income from GECC  -   -   -  (490)  (490)
Transaction and integration costs  540   -   -  291   831 
Pharmacy buildout  65   -   -  -   65 
DME management and Monitoring fees  59   -   -  (34)  25 
Adjusted EBITDA $ 2,526  $ 307  $ 1,151 $ (1,403) $ 2,581 
           
           
  For the nine months ended March 31, 2020
$ in thousands Durable Medical
Equipment
 Investment
Management
 Real Estate General
Corporate
 Consolidated
EBITDA:          
Net income (loss) - GAAP $ (2,893) $ 451  $ 187 $ (14,968) $ (17,223)
Interest expense  2,839   122   1,967  155   5,083 
Depreciation & amortization  7,344   508   1,291  2   9,145 
Income tax expense (benefit)  -   -   -  (5)  (5)
EBITDA $ 7,290  $ 1,081  $ 3,445 $ (14,816) $ (3,000)
Adjusted EBITDA:          
Stock based compensation  -   (100)  -  334   234 
Change in contingent consideration   -   -   -  (1,135)  (1,135)
GECC Unrealized (gains) / losses  -   -   -  11,603   11,603 
Dividend income from GECC  -   -   -  (1,567)  (1,567)
Other (income) expense  (3)  -   -  -   (3)
Transaction and integration costs   1,276   -   -  926   2,201 
Pharmacy buildout  320   -   -  -   320 
DME management and Monitoring fees  189   -   -  (114)  75 
Adjusted EBITDA $ 9,071  $ 981  $ 3,445 $ (4,768) $ 8,729 
           
           
  For the three months ended March 31, 2019
$ in thousands Durable Medical
Equipment
 Investment
Management
 Real Estate General
Corporate
 Consolidated
EBITDA:          
Net income (loss) - GAAP $ (517) $ (163) $ 38 $ 4,843  $ 4,201 
Net income from discontinued operations  -   -   -  (3,879)  (3,879)
Interest expense  998   47   667  -   1,712 
Depreciation & amortization  2,275   180   436  -   2,891 
Income tax expense (benefit)  -   -   -  (1,229)  (1,229)
EBITDA $ 2,756  $ 64  $ 1,141 $ (265) $ 3,696 
Adjusted EBITDA:          
Stock based compensation  -   19   -  83   102 
GECC Unrealized (gains) / losses  599   -   -  (1,406)  (807)
Dividend income from GECC  (198)  -   -  (292)  (490)
Transaction and integration costs   7   219   -  396   622 
Pharmacy buildout  58   -   -  -   58 
DME management and monitoring fees  (5)  -   -  5   - 
Adjusted EBITDA $ 3,217  $ 302  $ 1,141 $ (1,479) $ 3,181 
           
           
  For the nine months ended March 31, 2019
$ in thousands Durable Medical
Equipment
 Investment
Management
 Real Estate General
Corporate
 Consolidated
EBITDA:          
Net income (loss) - GAAP $ (91) $ (859) $ 127 $ (1,261) $ (2,084)
Net income from discontinued operations  -   -   -  (3,786)  (3,786)
Interest expense  2,365   135   1,995  -   4,495 
Depreciation & amortization  4,840   453   1,298  -   6,591 
Income tax expense (benefit)  -   -   -  (1,229)  (1,229)
EBITDA $ 7,114  $ (271) $ 3,420 $ (6,276) $ 3,987 
Adjusted EBITDA:          
Stock based compensation  -   601   -  343   944 
GECC Unrealized (gains) / losses  1,010   -   -  917   1,927 
Dividend income from GECC  (629)  -   -  (1,312)  (1,941)
Transaction and integration costs   551   219   -  1,855   2,625 
Pharmacy buildout  58   -   -  -   58 
DME management and Monitoring fees  65   -   -  (65)  - 
Adjusted EBITDA $ 8,169  $ 549  $ 3,420 $ (4,538) $ 7,600 
           

(1) Prior year non-GAAP adjustments have been updated to conform to current year presentation by removing adjustments associated with the adoption of ASC 606 Contracts with Customers.


Media & Investor Contact:

Investor Relations
+1 (617) 375-3006
investorrelations@greatelmcap.com